NewEdge Advisors’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-17
| Closed | -$84 | – | 4268 |
|
|
2025
Q3 | $84 | Hold |
17
| – | – | ﹤0.01% | 4039 |
|
|
2025
Q2 | $44 | Hold |
17
| – | – | ﹤0.01% | 3933 |
|
|
2025
Q1 | $47 | Hold |
17
| – | – | ﹤0.01% | 3856 |
|
|
2024
Q4 | $75 | Hold |
17
| – | – | ﹤0.01% | 3801 |
|
|
2024
Q3 | $81 | Hold |
17
| – | – | ﹤0.01% | 3727 |
|
|
2024
Q2 | $110 | Hold |
17
| – | – | ﹤0.01% | 3684 |
|
|
2024
Q1 | $127 | Hold |
17
| – | – | ﹤0.01% | 3697 |
|
|
2023
Q4 | $218 | Hold |
17
| – | – | ﹤0.01% | 3600 |
|
|
2023
Q3 | $287 | Hold |
17
| – | – | ﹤0.01% | 3297 |
|
|
2023
Q2 | $343 | Hold |
17
| – | – | ﹤0.01% | 3346 |
|
|
2023
Q1 | $395 | Hold |
17
| – | – | ﹤0.01% | 3263 |
|
|
2022
Q4 | $1 | Buy |
+17
| New | +$375 | ﹤0.01% | 4001 |
|
NewEdge Advisors's EVOK Position: Q4 2025 in Review
NewEdge Advisors sold out of Evoke Pharma (EVOK) in Q4 2025, closing a stake of 17 shares — an estimated $84 sold.
NewEdge Advisors first reported a position in EVOK in Q4 2022 and held it in 12 quarters. The position peaked at $395 in Q1 2023. 0 funds tracked by Wall St. Rank hold EVOK as of Q4 2025.
- NewEdge Advisors reported no remaining Evoke Pharma position as of Q4 2025 after selling out during the quarter.
- NewEdge Advisors sold 17 Evoke Pharma shares in Q4 2025, an estimated $84.
- NewEdge Advisors first reported a position in Evoke Pharma in Q4 2022 and held it in 12 quarters.
- NewEdge Advisors's Evoke Pharma position peaked at $395 in Q1 2023.
- 0 funds tracked by Wall St. Rank held Evoke Pharma as of Q4 2025.
Based on NewEdge Advisors's 13F filing for Q4 2025, filed 18 Feb 2026.